Evidence map›Paper›PMID 38414538›Full record

ArticleInternational journal of population data science2023

Generating synthetic data from administrative health records for drug safety and effectiveness studies.

Olawale F Ayilara, Robert W Platt, Matt Dahl, Janie Coulombe, Pablo Gonzalez Ginestet, Dan Chateau, Lisa M Lix

Open access · goldAbstract read
In one paragraph

Article in International journal of population data science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Synthetic health data in Canada: A scoping review of methods, applications, and data sources.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Olawale F AyilaraDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Robert W PlattDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
Matt DahlManitoba Centre for Health Policy, University of Manitoba, Winnipeg, Canada.
Janie CoulombeDepartment of Mathematics and Statistics, Université de Montréal, Montreal, Canada.
Pablo Gonzalez GinestetDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Dan ChateauCollege of Health & Medicine, Australian National University, Canberra, Australia.
Lisa M LixDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
University of Manitoba · CAAustralian National University · AUKarolinska Institutet · SEManitoba Health · CAMcGill University · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Administrative health records (AHRs) are used to conduct population-based post-market drug safety and comparative effectiveness studies to inform healthcare decision making. However, the cost of data extraction, and the challenges associated with privacy and securing approvals can make it challenging for researchers to conduct methodological research in a timely manner using real data. Generating synthetic AHRs that reasonably represent the real-world data are beneficial for developing analytic methods and training analysts to rapidly implement study protocols. We generated synthetic AHRs using two methods and compared these synthetic AHRs to real-world AHRs. We described the challenges associated with using synthetic AHRs for real-world study. Methods: The real-world AHRs comprised prescription drug records for individuals with healthcare insurance coverage in the Population Research Data Repository (PRDR) from Manitoba, Canada for the 10-year period from 2008 to 2017. Synthetic data were generated using the Observational Medical Dataset Simulator II (OSIM2) and a modification (ModOSIM). Synthetic and real-world data were described using frequencies and percentages. Agreement of prescription drug use measures in PRDR, OSIM2 and ModOSIM was estimated with the concordance coefficient. Results: The PRDR cohort included 169,586,633 drug records and 1,395 drug types for 1,604,734 individuals. Synthetic data for 1,000,000 individuals were generated using OSIM2 and ModOSIM. Sex and age group distributions were similar in the real-world and synthetic AHRs. However, there were significant differences in the number of drug records and number of unique drugs per person for OSIM2 and ModOSIM when compared with PRDR. For the average number of days of drug use, concordance with the PRDR was 16% (95% confidence interval [CI]: 12%-19%) for OSIM2 and 88% (95% CI: 87%-90%) for ModOSIM. Conclusions: ModOSIM data were more similar to PRDR than OSIM2 data on many measures. Synthetic AHRs consistent with those found in real-world settings can be generated using ModOSIM. Synthetic data will benefit rapid implementation of methodological studies and data analyst training.

Indexed as

Prescription DrugsCanadaHumansInsurance CoverageManitobaResearch DesignPrescription Drugsadministrative health recordscomputer simulationprescription drug recordsvalidation

Identifiers

PMID38414538
PMCPMC10898503
OpenAlexW4389036121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.